Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 5,293 shares at $2.12 ($11K) on 2023-12-20, disclosed to the SEC on 2023-12-21.
Open-market sale of $11k VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |
| VTYX | SELL | 2023-07-05 | $1.1M | — | Filing → |